Call
Sales
866 - 285 - 7215
1-781-489-7301

Biotechnology

Proteomics: An Assessment of Technology and Commercial Potential

The table of contents is not available online, please contact us for further information or look on the right hand column to see if there is a more recent version of the report

REPORT HIGHLIGHTS

  • Proteomics is an emerging field that has developed in the wake of genomics. Its goal is to understand protein expression at the cellular level, and apply this information to scientific and medical problems. For example, compared to healthy cells, how does influenza virus infection affect the total protein output? Are any of the proteins expressed only in the infected cells suitable targets for new antiviral drugs? This approach also applies to cancerous cells, and cells from patients with degenerative diseases and many other conditions. New technologies like protein chips and capillary electrophoresis are emerging to serve proteomic studies, and more mature technologies like 2-D electrophoresis, mass spectroscopy, and nuclear magnetic resonance spectroscopy are being adapted for protein studies, and in some cases, for high throughput uses. Bioinformatics applications are constantly being developed to analyze the data produced by all of these technologies.
  • This BCC study examines how proteomics technologies have affected basic research and pharmaceutical research, and how they are likely to affect research in the near future. It also analyzes how proteomics technologies are developing, and examines new companies that are likely to make substantial contributions to the field. An important part of the report analyzes instruments that are vital to proteomics studies. Sales and spending projections through 2006 are included.

SUMMARY FIGURE
REVENUES FOR SELECTED PROTEOMICS-RELATED PRODUCTS,* WORLDWIDE FORECAST, 2000, 2001 AND 2006
($ Millions)
Source: BCC, Inc.